Ascendis Pharma A/S (ASND) released Loss for second quarter that decreased from last year but missed the Street estimates.
The company's bottom line totaled -Euro109.4 million, or -Euro1.91 per share. This compares with -Euro121.4 million, or -Euro2.16 per share, in last year's second quarter.
Analysts on average had expected the company to earn -Euro1.56 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 24.0% to Euro35.998 million from Euro47.393 million last year.
Ascendis Pharma A/S earnings at a glance (GAAP) :
-Earnings (Q2): -Euro109.4 Mln. vs. -Euro121.4 Mln. last year.
-EPS (Q2): -Euro1.91 vs. -Euro2.16 last year.
-Revenue (Q2): Euro35.998 Mln vs. Euro47.393 Mln last year.
For comments and feedback: editorial@rttnews.com